Şunu aradınız:: bioprieinamumas (Litvanca - İngilizce)

absoliutus bioprieinamumas – 76 %.
the absolute bioavailability is 76%.

absoliutus bioprieinamumas ­ 76%.
the absolute bioavailability is 76%.

absoliutusis bioprieinamumas nebuvo tirtas.
the absolute bioavailability of victrelis has not been studied.

absoliutus lumirakoksibo bioprieinamumas yra mazdaug 74%.
the absolute bioavailability of lumiracoxib is approximately 74%.

sušvirkštus po oda, absoliutus bioprieinamumas yra apie 70.
following subcutaneous administration, the absolute bioavailability is about 70%.

susvirkstus po oda, absoliutus bioprieinamumas yra apie 70%.
following subcutaneous administration, the absolute bioavailability is about 70%.

manoma, kad visiškas bioprieinamumas sudaro maždaug 100 %.
absolute bioavailability is estimated to be approximately 100%.

isgerto pregabalino bioprieinamumas yra 90% ir nepriklauso nuo dozs.
pregabalin oral bioavailability is estimated to be 90% and is independent of dose.

susvirkstus po oda, absoliutus vaisto bioprieinamumas yra apie 70%.
following subcutaneous administration, the absolute bioavailability is about 70%.

absorbcija po poodinės injekcijos absoliutusis ikatibanto bioprieinamumas yra 97%.
absorption following subcutaneous administration, the absolute bioavailability of icatibant is 97%.

išgerto pregabalino bioprieinamumas yra ≥ 90 % ir nepriklauso nuo dozės.
pregabalin oral bioavailability is estimated to be ≥ 90% and is independent of dose.

farmakokinetiniai modeliai parodė, kad absoliutus bioprieinamumas vartojant po oda yra 72 %.
the absolute bioavailability after sc dosing was determined to be 72% from pharmacokinetic models.

absoliutus insulino detemiro bioprieinamumas, atliekant poodin injekcij, yra mazdaug 60%.
the absolute bioavailability of insulin detemir when administered subcutaneous is approximately 60%.

vienos 30 mg paros dozės ir kartotinų dienos dozių bioprieinamumas yra 80- 90%.
bioavailability after a single dose of 30 mg and after repeated daily administration is 80-90%.

p-glikorpoteino inhibitoriai (pav. ciklosporinas) gali didinti atorvastatinio bioprieinamum.
inhibitors of the p-glycoprotein (e. g. ciclosporin) can increase the bioavailability of atorvastatin.